Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level - PubMed (original) (raw)
Comparative Study
. 2006 May;87(Pt 5):1247-1257.
doi: 10.1099/vir.0.81361-0.
Affiliations
- PMID: 16603527
- DOI: 10.1099/vir.0.81361-0
Comparative Study
Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level
Nathalie Alazard-Dany et al. J Gen Virol. 2006 May.
Abstract
Transient expression of Ebola virus (EBOV) glycoprotein GP causes downregulation of surface proteins, cell rounding and detachment, a phenomenon believed to play a central role in the pathogenicity of the virus. In this study, evidence that moderate expression of GP does not result in such morphological changes was provided. It was shown that GP continuously produced in 293T cells from the Kunjin virus replicon was correctly processed and transported to the plasma membrane without affecting the surface expression of beta1 and alpha5 integrins and major histocompatibility complex I molecules. The level of GP expression in Kunjin replicon GP-expressing cells was similar to that observed in cells infected with EBOV early in infection and lower than that produced in cells transfected with plasmid DNA, phCMV-GP, expressing GP from a strong promoter. Importantly, transient transfection of Kunjin replicon GP-expressing cells with GP-coding plasmid DNA resulted in overexpression of GP, which lead to the downregulation of surface molecules and massive rounding and detachment of transfected cells. Here, it was also demonstrated that cell rounding and downregulation of the surface markers are the late events in EBOV infection, whereas synthesis and massive release of virus particles occur at early steps and do not cause significant cytotoxic effects. These findings indicate that the synthesis of EBOV GP in virus-infected cells is controlled well by several mechanisms that do not allow GP overexpression and hence the early appearance of its cytotoxic properties.
Similar articles
- Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.
Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P. Simmons G, et al. J Virol. 2002 Mar;76(5):2518-28. doi: 10.1128/jvi.76.5.2518-2528.2002. J Virol. 2002. PMID: 11836430 Free PMC article. - A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
González-Hernández M, Hoffmann M, Brinkmann C, Nehls J, Winkler M, Schindler M, Pöhlmann S. González-Hernández M, et al. J Virol. 2018 Jun 13;92(13):e00403-18. doi: 10.1128/JVI.00403-18. Print 2018 Jul 1. J Virol. 2018. PMID: 29669839 Free PMC article. - [Research progress on ebola virus glycoprotein].
Ding GY, Wang ZY, Gao L, Jiang BF. Ding GY, et al. Bing Du Xue Bao. 2013 Mar;29(2):233-7. Bing Du Xue Bao. 2013. PMID: 23757858 Review. Chinese. - Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.
Dolnik O, Volchkova VA, Escudero-Perez B, Lawrence P, Klenk HD, Volchkov VE. Dolnik O, et al. J Infect Dis. 2015 Oct 1;212 Suppl 2:S322-8. doi: 10.1093/infdis/jiv268. Epub 2015 Jun 19. J Infect Dis. 2015. PMID: 26092855 - Molecular Mechanism of Externalization of Phosphatidylserine on the Surface of Ebola Virus Particles.
Nanbo A, Kawaoka Y. Nanbo A, et al. DNA Cell Biol. 2019 Feb;38(2):115-120. doi: 10.1089/dna.2018.4485. Epub 2019 Jan 7. DNA Cell Biol. 2019. PMID: 30615471 Review.
Cited by
- Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure.
Mehedi M, Hoenen T, Robertson S, Ricklefs S, Dolan MA, Taylor T, Falzarano D, Ebihara H, Porcella SF, Feldmann H. Mehedi M, et al. PLoS Pathog. 2013;9(10):e1003677. doi: 10.1371/journal.ppat.1003677. Epub 2013 Oct 17. PLoS Pathog. 2013. PMID: 24146620 Free PMC article. - Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.
Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, Volchkov VE. Reynard O, et al. J Virol. 2009 Sep;83(18):9596-601. doi: 10.1128/JVI.00784-09. Epub 2009 Jul 8. J Virol. 2009. PMID: 19587051 Free PMC article. - RNF185 regulates proteostasis in Ebolavirus infection by crosstalk between the calnexin cycle, ERAD, and reticulophagy.
Zhang J, Wang B, Gao X, Peng C, Shan C, Johnson SF, Schwartz RC, Zheng YH. Zhang J, et al. Nat Commun. 2022 Oct 12;13(1):6007. doi: 10.1038/s41467-022-33805-9. Nat Commun. 2022. PMID: 36224200 Free PMC article. - Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells.
Kühl A, Hoffmann M, Müller MA, Munster VJ, Gnirss K, Kiene M, Tsegaye TS, Behrens G, Herrler G, Feldmann H, Drosten C, Pöhlmann S. Kühl A, et al. J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S840-9. doi: 10.1093/infdis/jir306. J Infect Dis. 2011. PMID: 21987760 Free PMC article. - Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein.
Xiao JH, Rijal P, Schimanski L, Tharkeshwar AK, Wright E, Annaert W, Townsend A. Xiao JH, et al. J Virol. 2018 Jan 30;92(4):e00941-17. doi: 10.1128/JVI.00941-17. Print 2018 Feb 15. J Virol. 2018. PMID: 29212933 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical